Pharmacotherapy for T2DM includes insulin analogues, biguanids, sulfonylureas, α-glucosidase inhibitors, thiazolidinediones, SGLT-2-inhibitors, GLP-1 analogues, DPP-4-inhibitors, amylin analogues. This evidence concerns the gene INS and type 2 diabetes mellitus.